Study of DNA patterns in childhood germ cell tumors
Treatments studied
Part of Cancer, Women’s health & pregnancy clinical trials.
This study looks at “molecular” (DNA-related) features of germ cell tumors in children and teens. It also follows patients over time, which can help researchers understand tumor patterns and improve future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with a germ cell tumor (including types like germinoma, teratoma, yolk sac tumor, choriocarcinoma, embryonal carcinoma, or mixed types)
- Your germ cell tumor diagnosis happened before age 20
- You are enrolled in the Children’s Oncology Group studies APEC14B1 (with permission for future contact) or AEPI10N1 (with permission for future contact)
- You can complete study forms and paperwork in English or Spanish
- You (and your parent/legal guardian) can give informed consent; children ages 8–17 also give assent
- Your care team/center can meet all required study rules (institution, FDA, and NCI)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how to manage germ cell tumors in children and young adults using careful monitoring for some patients and chemotherapy for others. It aims to see whether these approaches can control the cancer while avoiding unnecessary treatment when possible.
This study collects DNA and medical information to better understand germ cell and testicular tumors and possible inherited genetic causes. It may help researchers sort out how genetic changes relate to these cancers, even if you’re not receiving a new drug.
This Phase 2 study tests a new treatment approach for certain brain tumors called NGGCT in children and young adults. It may help improve outcomes by targeting tumors in specific brain locations and using tumor marker tests to guide care.
This study looks at long-term health problems and quality of life in people who survived germ cell tumors after strong chemotherapy with a stem cell transplant or other standard treatments. It may help doctors understand which late side effects are most common and how to better support survivors.
This study looks at genetic (DNA/molecular) features of malignant brain tumors in children. It may help doctors better understand tumor risk patterns and guide future treatment planning.
This trial looks at tiny molecules in the blood to help diagnose ovarian germ cell tumors. It compares results from people with malignant (cancerous) tumors, benign (non-cancerous) tumors, and those without any gynecologic condition.
Hear when a new Germ Cell Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.